Skip to main content
XOMA Royalty Corp logo

XOMA Royalty Corp — Investor Relations & Filings

Ticker · XOMA ISIN · US98419J3059 US Financial and insurance activities
Open in API
Filings indexed 1,095 across all filing types
Latest filing 2025-04-15 Annual Report
Country US United States of America
Listing US XOMA

About XOMA Royalty Corp

https://xoma.com/

XOMA Royalty Corp. is a biotech royalty aggregator that acquires economic rights to potential future milestone and royalty payments. The company's portfolio consists of assets associated with pre-commercial clinical candidates being developed by various pharmaceutical and biotech partners. In exchange for these economic rights, XOMA provides its partners with non-dilutive, non-recourse capital to fund their internal drug development programs. This portfolio-based strategy, encompassing over 120 assets, is designed to diversify risk away from single-asset clinical outcomes. XOMA focuses on managing these royalty assets rather than direct drug development.

Recent filings

Filing Released Lang Actions
ARS
Annual Report
2025-04-15 English
DEF 14A
Proxy Solicitation & Information Statement
2025-04-15 English
PRIMARY DOCUMENT
Director's Dealing
2025-04-09 English
PRIMARY DOCUMENT
Director's Dealing
2025-04-07 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Proxy Statement filed on Schedule 14A with the SEC, as indicated by the header and the text. It is a preliminary proxy statement for the annual meeting of stockholders of XOMA Royalty Corporation, detailing proposals to be voted on, including election of directors, auditor ratification, reincorporation, by-law amendments, and stock award plan approval. It includes detailed information about the meeting, voting instructions, and governance matters. Proxy Statements are materials sent to shareholders to provide information and solicit votes for meetings, matching the definition of Proxy Solicitation & Information Statement (PSI). The document is lengthy (15,000 characters) and contains substantive content typical of a proxy statement, not just an announcement or a brief notice. Therefore, the correct classification is PSI with high confidence.
2025-04-04 English
PRIMARY DOCUMENT
Director's Dealing
2025-04-02 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.